439117-39-2 Usage
Description
[2-(AMINOMETHYL)-5-CHLOROPHENYL]METHANOL, with the molecular formula C8H10ClNO, is an organic compound characterized by a benzene ring with a chloro group and an aminomethyl group. It is recognized for its potential as a building block in the synthesis of pharmaceuticals and agrochemicals, as well as its possible biological activities and therapeutic applications.
Uses
Used in Pharmaceutical Synthesis:
[2-(AMINOMETHYL)-5-CHLOROPHENYL]METHANOL is used as a key intermediate in the pharmaceutical industry for the synthesis of various complex molecules. Its unique structure allows for the creation of a wide range of therapeutic agents.
Used in Agrochemical Synthesis:
In the agrochemical industry, [2-(AMINOMETHYL)-5-CHLOROPHENYL]METHANOL is utilized as a starting material for the development of new compounds with potential applications in agriculture, such as pesticides and herbicides.
Used in Biological Research:
[2-(AMINOMETHYL)-5-CHLOROPHENYL]METHANOL is also used in biological research as a compound of interest for studying its potential biological activities and therapeutic applications, which may lead to the discovery of new treatments for various diseases and conditions.
Safety and Handling:
It is crucial to handle and use [2-(AMINOMETHYL)-5-CHLOROPHENYL]METHANOL safely and in accordance with proper guidelines and regulations to minimize any potential risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 439117-39-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,9,1,1 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 439117-39:
(8*4)+(7*3)+(6*9)+(5*1)+(4*1)+(3*7)+(2*3)+(1*9)=152
152 % 10 = 2
So 439117-39-2 is a valid CAS Registry Number.
439117-39-2Relevant articles and documents
PYRROLIDINE THROMBIN INHIBITORS
-
, (2014/03/21)
Compounds of the invention, which may be useful in inhibiting thrombin and associated thrombotic occlusions, have the following structure: (I) or a pharmaceutically acceptable salt thereof, wherein R is a heterocycle or -(CR4R5)1-2NH2 , wherein R4 and R5,
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailability
Morrissette, Matthew M.,Stauffer, Kenneth J.,Williams, Peter D.,Lyle, Terry A.,Vacca, Joseph P.,Krueger, Julie A.,Lewis, S. Dale,Lucas, Bobby J.,Wong, Bradley K.,White, Rebecca B.,Miller-Stein, Cynthia,Lyle, Elizabeth A.,Wallace, Audrey A.,Leonard, Yvonne M.,Welsh, Denise C.,Lynch, Joseph J.,McMasters, Daniel R.
, p. 4161 - 4164 (2007/10/03)
Modification of lead compound 1 by reducing lipophilicity in the P3 group produced a series of low molecular weight thrombin inhibitors with excellent potency in functional assays, metabolic stability, and oral bioavailability. These modifications led to
Thrombin inhibitors
-
, (2008/06/13)
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: or a pharmaceutically acceptable salt thereof, e.g. 1-(3(S)-Cyclopropyl-2(R)-hydroxybutanoyl)azetidine-2(S)-N-(2-aminomethyl-5-chlorobenzyl)carboxamide, and 1-(3-Cyclopropyl-3-methyl-2(R)-hydroxybutanoyl)azetidine-2(S)-N-(2-aminomethyl-5-chlorobenzyl)carboxamide.
